share_log

ステラファーマがランクイン、再発乳がん対象のホウ素中性子捕捉療法の臨床研究で論文掲載

Stellar Pharma ranked and published a paper in clinical research on boron neutron capture therapy for recurrent breast cancer

Fisco ·  Apr 3 13:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Login or create a forever free account to read this news
Sign up/Log in

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment